glp 1 als GLP-1 agonists linked to faster progression of some neurological diseases Full article: Targeting metabolic dysfunction
Description
The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.
TUESDAY, July 15, 2025 (HealthDay News) Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says.P
Why PatchAid
Research shows that GlucoVantage substantially increases your own bodys natural GLP-1 production
GLP-1 medications may increase kidney stone risk through dehydration and uric acid changes, but individual risk depends on baseline kidney function, hydration status, and metabolic factors
Its pathogenesis is unknown
